Posts

Johnson & Johnson is getting rid of its script logo aft...

Johnson & Johnson will replace the well-known signature script in its logo with ...

Listen: Covid’s latest surge, Alnylam at the FDA, & the...

What does Covid-19 have in store for the winter? When are good data not good eno...

STAT+: House subcommittee forays into fixing drug short...

A House subcommittee took a first step today toward legislation to fix drug shor...

STAT+: FTC warns drugmakers they can face legal action ...

The FTC warned pharmaceutical companies they could face legal action if they imp...

STAT+: Dana-Farber, in break with Brigham and Women’s, ...

“We would like to believe that a new inpatient hospital solely dedicated to adul...

Pig kidney works a record two months in donated body, r...

A pig kidney worked for a record two months in donated body, raising hope for te...

New Senate deal would ban some facility fees, reform ho...

A bipartisan deal to fund primary care programs led by Sens. Bernie Sanders (I-V...

STAT+: Medicare is urged to monitor how rebates affect ...

Medicare should monitor the effect that rebates have on Part D plans and whether...

STAT+: New study adds to evidence on psychedelic as eff...

MDMA is a safe and effective treatment for post-traumatic stress disorder in a r...

STAT+: Pharmalittle: White House imposes price limits f...

A HHS deal for a Regeneron drug marks the first time the administration has dire...

STAT+: Machine learning biotech raises $273 million in ...

Biotech startup Generate Biomedicines, which uses AI to find new drugs, raised $...

The ‘Hispanic Paradox’ intrigues a new generation of re...

With better data, powerful genomic tools, and a rich cultural awareness of the c...

STAT+: Civica Rx considers moving into chemo drugs as s...

A hospital nonprofit formed to deal with drug shortages, Civica Rx, is consideri...

Novelist John Green launches attack on Cepheid over the...

John Green, a novelist and popular YouTuber, is once again leveraging his star p...

Opinion: Long Covid is a new name for an old syndrome

Although much about ME/CFS is still not well-understood, decades of experience a...

STAT+: FDA panel endorses Alnylam’s heart drug — after ...

“It’s like a light wind blowing in favor of patisiran over placebo,” said David ...